secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orchestra BioMed Holdings, Inc. (OBIO)
CIK:        0001814114
Form:       8-K
Filed at:   2024-07-30T23:59:59+00:00
Accession:  0001104659-24-083973
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orchestra BioMed appoints John Mack to board; former Medtronic Cardiac Surgery President
--------------------------------------------------------------------------------

- John Mack appointed as Class I director effective July 29, 2024; term expires at 2027 annual meeting.
- Mack previously served as Medtronic's President of Cardiac Surgery and led business development for its $3.2B coronary/structural heart business.
- Appointed to Audit Committee; Board size increased from 7 to 8 directors.
- No family relationships or transactions requiring disclosure under Item 404(a).
- Mack will receive standard non-employee director compensation per existing policy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1814114/000110465924083973/0001104659-24-083973-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1814114/000110465924083973/tm2420397d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-083973

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer